Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Carcinoma of the Upper Urinary Tract A Study Using Dual-color In Situ Hybridization and Immunohistochemistry

Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Carcinoma of the... RESEARCH ARTICLE Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Carcinoma of the Upper Urinary Tract: A Study Using Dual-color In Situ Hybridization and Immunohistochemistry Marie Vershasselt-Crinquette, MD,* Pierre Colin, MD,w Adil Ouzzane, MD,w Viviane Gnemmi, MD,* Yves-Marie Robin, MD,z Sebastien Aubert, MD, PhD,* Arnauld Villers, MD, PhD,w and Xavier Leroy, MD, PhD* pper urinary tract urothelial carcinoma (UUTUC) is Aim: Upper urinary tract urothelial carcinoma (UUTUC) is an Ua rare adult malignant neoplasm. UUTUCs present uncommon neoplasm frequently discovered at a high-stage many similarities with tumors of the bladder but are disease. The prognosis of disseminated UUTUCs is poor despite characterized by a less favorable prognosis in relation 1–3 the use of platinum-based chemotherapy. The aim of the study with a late diagnosis. UUTUCs are also remarkable was to evaluate HER2 overexpression and amplification in a because these tumors belong to the spectrum of Lynch series of 83 UUTUCs. syndrome. The prognosis of high-grade and high-stage tumors is poor despite the use of platinum-based che- Materials and Methods: All tumors were formalin fixed. TNM motherapy. Anti-HER2 therapy is well established in stage, grade, lymphovascular invasion, surgical margins, mor- breast carcinoma with overexpression/amplification of phologic variants http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Applied Immunohistochemistry & Molecular Morphology Wolters Kluwer Health

Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Carcinoma of the Upper Urinary Tract A Study Using Dual-color In Situ Hybridization and Immunohistochemistry

Loading next page...
 
/lp/wolters-kluwer-health/assessment-of-human-epidermal-growth-factor-receptor-2-status-in-0aHTtrlmLK

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2012 by Lippincott Williams & Wilkins
ISSN
1541-2016
DOI
10.1097/PAI.0b013e318241cab9
pmid
22495372
Publisher site
See Article on Publisher Site

Abstract

RESEARCH ARTICLE Assessment of Human Epidermal Growth Factor Receptor 2 Status in Urothelial Carcinoma of the Upper Urinary Tract: A Study Using Dual-color In Situ Hybridization and Immunohistochemistry Marie Vershasselt-Crinquette, MD,* Pierre Colin, MD,w Adil Ouzzane, MD,w Viviane Gnemmi, MD,* Yves-Marie Robin, MD,z Sebastien Aubert, MD, PhD,* Arnauld Villers, MD, PhD,w and Xavier Leroy, MD, PhD* pper urinary tract urothelial carcinoma (UUTUC) is Aim: Upper urinary tract urothelial carcinoma (UUTUC) is an Ua rare adult malignant neoplasm. UUTUCs present uncommon neoplasm frequently discovered at a high-stage many similarities with tumors of the bladder but are disease. The prognosis of disseminated UUTUCs is poor despite characterized by a less favorable prognosis in relation 1–3 the use of platinum-based chemotherapy. The aim of the study with a late diagnosis. UUTUCs are also remarkable was to evaluate HER2 overexpression and amplification in a because these tumors belong to the spectrum of Lynch series of 83 UUTUCs. syndrome. The prognosis of high-grade and high-stage tumors is poor despite the use of platinum-based che- Materials and Methods: All tumors were formalin fixed. TNM motherapy. Anti-HER2 therapy is well established in stage, grade, lymphovascular invasion, surgical margins, mor- breast carcinoma with overexpression/amplification of phologic variants

Journal

Applied Immunohistochemistry & Molecular MorphologyWolters Kluwer Health

Published: Jul 1, 2012

There are no references for this article.